Advertisement

Picture EBD Group BioPharm America 2017 BPA Boston MA September 600x60px
Document › Details

Proteome Sciences plc. (10/30/13). "Press Release: Proteome Sciences Appoints Director of Personalised Medicine".

Organisations Organisation Proteome Sciences plc
  Group Proteome Sciences (Group)
  Organisation 2 Roche (Group)
Products Product proteomic services
  Product 2 personalised medicine / precision medicine
Persons Person See, Chee Gee (Proteome Sciences 201310– Director Personalised Medicine with BusDev taks before Roche + GSK)
  Person 2 Pearce, Christopher (Proteome Sciences 201606– Non-executive Chairman before CEO)
     


Proteome Sciences is pleased to announce it has appointed Dr Chee Gee See as Director of Personalised Medicine with immediate effect.

Chee Gee is a biomarker and translational medicine expert, a former Biomarker and Experimental Medicine Leader for 5 years at Roche in multiple therapeutic areas including CNS, cardiovascular, respiratory and inflammation. Most notable was his role as the clinical oncology biomarker leader for the pivotal Phase III ToGA Herceptin trial and the codevelopment of the HER2 companion diagnostic in gastric cancer.

Prior to this Chee Gee spent 11 years at Glaxo Smith Kline where he was the European Therapeutic Area Analyst for Genetics Research reporting to Dr Allen Roses. He has specialist expertise in regulatory affairs and value-based drug pricing, reimbursement and market access.

Chee Gee's role at Proteome Sciences will be to extend its business development strategy and to strengthen the commercial relationships with pharmaceutical, clinical and academic partners globally.

Commenting on his appointment Christopher Pearce, CEO of Proteome Sciences, said:
"We are delighted to have Dr See join our team at this important juncture in Proteome Sciences' development as personalised medicine is becoming ever more critical in respect to disease diagnosis and prognosis, drug development and patient management. Chee Gee's skills are perfectly suited to enhance our growing reputation in this crucial field of medicine."

Dr See added:
"I have been extremely impressed with the outstanding and innovative science that underpins Proteome Sciences' commercial strategy and its range of powerful platform technologies and solutions. These meet the growing needs of the healthcare industry from diagnostics through to therapeutics and patient care and management in a dynamic and rapidly changing market place. I really look forward to working with the team at Proteome Sciences to extend its leading reputation in the markets it serves and to drive growth and revenue."

- Ends -

   
Record changed: 2016-01-10

Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px

More documents for Proteome Sciences (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture BIO Deutschland EBDC 2017 Heidelberg 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA September 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA September 120x180px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px